Follow-up of liver transplant recipients.


Journal

Best practice & research. Clinical gastroenterology
ISSN: 1532-1916
Titre abrégé: Best Pract Res Clin Gastroenterol
Pays: Netherlands
ID NLM: 101120605

Informations de publication

Date de publication:
Historique:
received: 10 07 2020
revised: 31 08 2020
accepted: 03 09 2020
entrez: 7 11 2020
pubmed: 8 11 2020
medline: 15 12 2020
Statut: ppublish

Résumé

The number of surviving liver allograft recipients is increasing almost exponentially. The quality and length of life is increasing but most recipients have reduced survival and quality of life compared with healthy matched individuals. Causes of premature death include cardio and cerebrovascular disease, renal failure, graft failure, de novo malignancy and recurrent disease. Follow-up is needed lifelong to ensure graft and patient health and ensure that complications are recognised and treated early. Immunosuppression is kept to the appropriate minimum and prophylactic interventions are given early, such as use of statins and tight control of blood pressure and blood sugar. Recipients will require life-long follow-up, and this is placing an increasing burden on transplant units. Follow-up is best done by close collaboration between the Liver Transplant Unit, the local hospital and primary care team. Involvement of other health care practitioners, such as recipient coordinators, pharmacists, dermatologists and addiction specialists may improve outcomes. Key to successful follow-up are agreed protocols and good communication between the recipients and all relevant health care providers. Use of IT allows for better communication and will support use of video and telephone consultations in selected instances. The most appropriate follow-up will depend on many factors, including logistic and geographic issues, local experience. The provision of well-funded and supported registries at local, national and international levels will allow for improvements in management.

Identifiants

pubmed: 33158465
pii: S1521-6918(20)30017-2
doi: 10.1016/j.bpg.2020.101682
pmc: PMC7485448
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

101682

Informations de copyright

Copyright © 2020 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest I have no conflicts of interest to declare.

Références

Gastroenterology. 2016 Feb;150(2):441-53.e6; quiz e16
pubmed: 26522262
Am J Transplant. 2009 Sep;9(9):1988-2003
pubmed: 19563332
Trials. 2018 Oct 19;19(1):574
pubmed: 30340637
Liver Transpl. 2017 Oct;23(10):1273-1281
pubmed: 28749550
World J Transplant. 2018 Feb 24;8(1):13-22
pubmed: 29507858
Clin Transplant. 2019 Sep;33(9):e13529
pubmed: 30859623
Transpl Int. 2018 Aug;31(8):870-879
pubmed: 29178601
BMC Public Health. 2019 Aug 07;19(1):1059
pubmed: 31391010
Liver Transpl. 2009 Oct;15(10):1330-5
pubmed: 19790168
Pediatr Transplant. 2017 Nov;21(7):
pubmed: 28670817
Am J Transplant. 2010 Aug;10(8):1889-96
pubmed: 20659094
Br J Dermatol. 2017 Nov;177(5):1225-1233
pubmed: 29086412
PLoS One. 2019 Dec 20;14(12):e0226686
pubmed: 31860656
Transplant Proc. 2019 Jan - Feb;51(1):38-40
pubmed: 30655136
Clin Transplant. 2012 May-Jun;26(3):382-6
pubmed: 22136467
Liver Transpl. 2011 Nov;17(11):1333-43
pubmed: 21770017
Alcohol Clin Exp Res. 2013 Sep;37(9):1601-8
pubmed: 23578009
Liver Transpl. 2013 Jan;19(1):3-26
pubmed: 23281277
Transpl Int. 2013 Jul;26(7):740-50
pubmed: 23714220
Am J Transplant. 2013 Sep;13(9):2384-94
pubmed: 23915357
Prog Transplant. 2017 Mar;27(1):48-52
pubmed: 27913799
Cochrane Database Syst Rev. 2015 Sep 07;(9):CD002098
pubmed: 26343551
Transplantation. 2019 Jul;103(7 Suppl 1):S1-S11
pubmed: 31259878
Liver Transpl. 2020 Aug;26(8):1052-1055
pubmed: 32369251
Gut. 2007 Feb;56(2):279-82
pubmed: 17008365
J Am Pharm Assoc (2003). 2015 Nov-Dec;55(6):613-620
pubmed: 26547595
Liver Transpl. 2003 Apr;9(4):321-30
pubmed: 12682881
Dig Dis Sci. 2019 May;64(5):1150-1157
pubmed: 30519848
Prog Transplant. 2018 Jun;28(2):100-115
pubmed: 29649931
Dig Dis Sci. 2019 Apr;64(4):1001-1007
pubmed: 30852770
Hepatol Int. 2015 Jul;9(3):461-70
pubmed: 25788182
Rev Med Suisse. 2019 Aug 28;15(660):1488-1495
pubmed: 31496172
Pharmacotherapy. 2012 Dec;32(12):1053-60
pubmed: 23165887
Br J Dermatol. 2019 Mar;180(3):631-636
pubmed: 30005137
Transplant Proc. 2019 Nov;51(9):2952-2957
pubmed: 31607623
PLoS One. 2013;8(2):e56974
pubmed: 23451126
N Z Med J. 2013 Feb 15;126(1369):27-33
pubmed: 23463107
Infect Dis Clin North Am. 2018 Sep;32(3):495-506
pubmed: 30146019
Transplant Proc. 2019 Apr;51(3):692-700
pubmed: 30979452
Transplant Proc. 2018 Apr;50(3):779-783
pubmed: 29661437
Transplantation. 2018 Feb;102(2):193-208
pubmed: 29381647
Liver Transpl. 2008 Aug;14(8):1092-9
pubmed: 18668665
Am J Transplant. 2010 Jun;10(6):1420-7
pubmed: 20486907
Liver Transpl. 2003 Dec;9(12):1295-307
pubmed: 14625830
Transpl Int. 2018 Aug;31(8):861-863
pubmed: 29763963

Auteurs

James Neuberger (J)

Liver Unit, Queen Elizabeth Hospital, Birmingham, UK. Electronic address: jamesneuberger@hotmail.co.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH